NCT03051061|UnknownDMC
Effect of Antithrombotic Treatment in Patients With Both Coronary Heart Disease and Atrial Fibrillation
ACHDAF
Loading search results
ACHDAF
Sponsor study identifier
observational
1,000
1 country
1
Study Start
February 1, 2017
Actual (reported)Primary Completion
December 1, 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 1, 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The optimal antithrombotic treatment for Coronary Heart disease (CHD) patients combined with Atrial Fibrillation (AF) is unresolved at present. Although the European and American guidelines have given a hand for us, there is absence of real-world data on the safety and efficacy of antithrombotic therapy in Asian populations. Only a few clinical trials are available to guide difficult decision on antithrombotic therapy in patients with combined AF and CHD，the investigators highlight the need for the rapid development of clinical trials to close the large gaps in evidence. This research aims to know the real-world use of antithrombotic treatment and clinical prognosis in Coronary Heart Disease patients complicated with Atrial Fibrillation.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 1, 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 1, 2017
Actual (reported)February 9, 2017
Actual (reported)February 13, 2017
Actual (reported)December 1, 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 1, 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Thromboembolism
including ischemic stroke and systemic embolization
1 year
Hemorrhage
1 year
Major Adverse Cardiovascular Events(MACE)
1 year
A composite outcome
1 year
patients with coexisting coronary heart disease and atrial fibrillation
Henan Provincial People's Hospital
Zhengzhou, Henan, 450000, China
Changyu Gao, PhD
Henan Provincial People's Hospital
You Zhang, PhD
Henan Provincial People's Hospital
Lili Wei, MD
Henan Provincial People's Hospital
First Submitted
February 9, 2017
First Posted
February 13, 2017
Study Start
February 1, 2017
Actual (reported)Primary Completion
December 1, 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Left Atrial Appendage Closure in Combination With Catheter Ablation
Contact the study team to confirm eligibility.
Study Completion
December 1, 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
December 12, 2019
Record last verified: 2019-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: